Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results

Trius Therapeutics Inc (TSRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/14/2014 SC 13G/A KPCB PANDEMIC & BIO DEFENSE FUND LLC reports a 0% stake in Trius Therapeutics, Inc.
09/13/2013 4 Finn John (Chief Scientific Officer) has filed a Form 4 on Trius Therapeutics Inc
09/13/2013 4 EASTHAM KARIN (Director) has filed a Form 4 on Trius Therapeutics Inc
Txns: Disposed/sold 6,000 shares @ $0
Disposed/sold 12,114 shares @ $0
Disposed/sold 17,441 options to buy @ $7.57, valued at $132k
Disposed/sold 6,000 options to buy @ $3.5, valued at $21k
Disposed/sold 12,000 options to buy @ $8.26, valued at $99.1k
Disposed/sold 12,000 options to buy @ $5.05, valued at $60.6k
Disposed/sold 15,000 options to buy @ $7.77, valued at $116.6k
09/13/2013 4 O'Leary Brendan (Director) has filed a Form 4 on Trius Therapeutics Inc
09/13/2013 4 Schmid John P. (CFO) has filed a Form 4 on Trius Therapeutics Inc
09/13/2013 4 TRUEX PAUL F (Director) has filed a Form 4 on Trius Therapeutics Inc
Txns: Disposed/sold 11,270 shares @ $0
Disposed/sold 12,403 options to buy @ $1.29, valued at $16k
Disposed/sold 12,000 options to buy @ $3.5, valued at $42k
Disposed/sold 12,000 options to buy @ $8.26, valued at $99.1k
Disposed/sold 12,000 options to buy @ $5.05, valued at $60.6k
Disposed/sold 15,000 options to buy @ $7.77, valued at $116.6k
09/13/2013 4 Bartizal Ken (Chief Development Officer) has filed a Form 4 on Trius Therapeutics Inc
09/13/2013 4 Prokocimer Philippe (Chief Medical Officer) has filed a Form 4 on Trius Therapeutics Inc
09/13/2013 4 MORNEAU MICHAEL (VP Finance & CAO) has filed a Form 4 on Trius Therapeutics Inc
09/13/2013 4 Stein Jeffrey (President & CEO) has filed a Form 4 on Trius Therapeutics Inc
Txns: Disposed/sold 210,457 shares @ $0
Disposed/sold 81,280 options to buy @ $0.52, valued at $42.3k
Disposed/sold 156,976 options to buy @ $1.29, valued at $202.5k
Disposed/sold 30,813 options to buy @ $1.29, valued at $39.7k
Disposed/sold 200,000 options to buy @ $3.5, valued at $700k
Disposed/sold 250,000 options to buy @ $4.8, valued at $1.2M
Disposed/sold 275,000 options to buy @ $6.13, valued at $1.7M
09/13/2013 4 KABAKOFF DAVID S (Director) has filed a Form 4 on Trius Therapeutics Inc
Txns: Disposed/sold 5,285 shares @ $0
Disposed/sold 106,081 shares @ $0
Disposed/sold 18,000 options to buy @ $3.5, valued at $63k
Disposed/sold 18,000 options to buy @ $8.26, valued at $148.7k
Disposed/sold 18,000 options to buy @ $5.05, valued at $90.9k
Disposed/sold 21,000 options to buy @ $7.77, valued at $163.2k
09/13/2013 4 Onaitis Matthew (General Counsel) has filed a Form 4 on Trius Therapeutics Inc
Txns: Disposed/sold 100,000 options to buy @ $7.67, valued at $767k
09/13/2013 4 Fischer Seth H.Z. (Director) has filed a Form 4 on Trius Therapeutics Inc
09/13/2013 4 ATWOOD BRIAN G (Director) has filed a Form 4 on Trius Therapeutics Inc
Txns: Disposed/sold 9,302 options to buy @ $1.29, valued at $12k
Disposed/sold 12,000 options to buy @ $3.5, valued at $42k
Disposed/sold 12,000 options to buy @ $8.26, valued at $99.1k
Disposed/sold 12,000 options to buy @ $5.05, valued at $60.6k
Disposed/sold 15,000 options to buy @ $7.77, valued at $116.6k
09/13/2013 4 Kjellson Nina S (Director) has filed a Form 4 on Trius Therapeutics Inc
Txns: Disposed/sold 9,302 options to buy @ $1.29, valued at $12k
Disposed/sold 12,000 options to buy @ $3.5, valued at $42k
Disposed/sold 12,000 options to buy @ $8.26, valued at $99.1k
Disposed/sold 12,000 options to buy @ $5.05, valued at $60.6k
Disposed/sold 15,000 options to buy @ $7.77, valued at $116.6k
09/13/2013 4 Schroeder Theodore R (Director) has filed a Form 4 on Trius Therapeutics Inc
Txns: Disposed/sold 15,116 options to buy @ $7.57, valued at $114.4k
Disposed/sold 12,000 options to buy @ $3.5, valued at $42k
Disposed/sold 12,000 options to buy @ $8.26, valued at $99.1k
Disposed/sold 12,000 options to buy @ $5.05, valued at $60.6k
Disposed/sold 15,000 options to buy @ $7.77, valued at $116.6k
09/13/2013 4 THOMPSON JOHN CRAIG (Chief Commercial Officer) has filed a Form 4 on Trius Therapeutics Inc
09/13/2013 SC 13D/A CUBIST PHARMACEUTICALS INC has filed a Schedule 13D for Trius Therapeutics Inc
09/11/2013 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
09/11/2013 8-K Quarterly results
09/11/2013 SC TO-T/A Form SC TO-T - Tender offer statement by Third Party [amend]
09/11/2013 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
09/05/2013 SC TO-T/A Form SC TO-T - Tender offer statement by Third Party [amend]
09/03/2013 SC TO-T/A Form SC TO-T - Tender offer statement by Third Party [amend]
08/29/2013 SC TO-T/A Form SC TO-T - Tender offer statement by Third Party [amend]
08/26/2013 SC 13D/A Form SC 13D - General statement of acquisition of beneficial ownership [amend]
08/14/2013 SC TO-T/A Form SC TO-T - Tender offer statement by Third Party [amend]
08/13/2013 SC 14D9 Form SC 14D9 - Solicitation, recommendation statements
08/13/2013 SC TO-T Form SC TO-T - Tender offer statement by Third Party
08/09/2013 SC 13D Trius Therapeutics Inc reports a 27.5% stake in TRIUS THERAPEUTICS, INC.
08/07/2013 10-Q Quarterly Report for the period ended June 30, 2013
08/06/2013 8-K Quarterly results
Docs: "TRIUS THERAPEUTICS REPORTS SECOND QUARTER 2013 FINANCIAL RESULTS"
08/02/2013 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party
08/01/2013 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy